Insmed Inc (STU:IM8N)
€ 67 0.5 (0.75%) Market Cap: 11.95 Bil Enterprise Value: 11.50 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 63/100

Insmed Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 13, 2019 / 03:00PM GMT
Release Date Price: €21.6 (+5.78%)
Graig Suvannavejh
Goldman Sachs Group Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay. Good morning, everyone. Welcome to day 3 of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I work on the biotech research efforts here at the firm.

Before I introduce Insmed and Will Lewis, I just have to read an obligatory disclaimer statement here, so bear with me.

We are required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We are prepared to read aloud disclosures for any issuer upon request. However, these disclosures are also available in our most recent reports available to you as clients on the firm's portal. Disclosures and updates to those disclosures are also available by ticker on the firm's public website. And finally, the views stated by non-Goldman Sachs personnel do not necessarily reflect those of Goldman Sachs.

So with that, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot